The eVTOL tape is giving investors three very different signals at once. Joby is showing some of the clearest certification and balance-sheet progress in the sector, Archer is still getting more visible institutional sponsorship despite messy production optics, and EHang just printed a profitable quarter while the stock keeps getting punished. Put those together, and the message is pretty clear: this market is not rewarding progress evenly. It is rewarding the version of progress that looks closest to commercial proof.
Today’s question set gets right to the heart of that mismatch. Joby has about $1.4 billion in cash and short-term investments, plus another $1.2 billion net received in February 2026, taking liquidity to roughly $2.6 billion. It also reported an 18-point increase in FAA Stage 4 progress and said its first FAA-conforming aircraft has already flown. Yet ARKX weights Joby at just 2.74% versus 4.10% for Archer. Meanwhile, Archer is keeping its 2026 pilot-program timeline intact even though public disclosure around actual finished aircraft count got weaker as 2025 went on. And EHang has a real Q4 profit number, but investors are still trading it like geographic concentration overwhelms the headline. Let’s break this down.
Q1: ARKX는 인증·현금 측면에서 더 앞서 보이는 Joby보다 Archer를 더 크게 들고 있다. Joby는 현금·단기투자 $1.4B에 2026년 2월 순유입 $1.2B까지 더해 총 약 $2.6B 수준의 유동성을 확보했고, FAA Stage 4에서 18포인트 진척과 첫 FAA-conforming 기체 비행까지 공개했는데도 ARKX 비중은 2.74%에 그친다. 반면 ACHR은 4.10%다. 시장의 ‘스마트머니’는 왜 인증 가시성보다 단기 상업화 스토리에 더 베팅하는가?
I think the simplest answer is that ETF managers are buying the timeline that looks easier to narrate to the market over the next 12 months, not necessarily the company with the cleanest long-duration risk profile.
On paper, Joby’s setup looks stronger. The company reported about $1.4 billion of cash and short-term investments in its Q4 2025 results, and then added roughly $1.2 billion of net proceeds in February 2026. That pushes total liquidity to around $2.6 billion. On the regulatory side, Joby also highlighted an 18-point gain in FAA Stage 4 progress and disclosed that its first FAA-conforming aircraft has already taken flight. Those are not cosmetic milestones. They directly support the view that Joby is moving deeper into the part of the certification process investors actually care about.
But ARKX is not running a certification-purity portfolio. It is running a thematic growth portfolio that needs visible catalysts, investor attention, and a storyline that can re-rate quickly. Archer offers that more easily right now.
Start with portfolio math. ARKX weights Archer at 4.10% and Joby at 2.74%. That 1.36 percentage-point gap is not small in a concentrated thematic ETF. It suggests ARK is more interested in the near-term commercial setup around Archer than in simply picking the company with the largest liquidity cushion or the most explicit certification datapoint.
Why? Because Archer’s story is easier to package as an “operations are about to happen” trade. Its 2026 U.S. and UAE pilot programs remain on track in company messaging. It also has White House pilot-program visibility in Florida, New York, and Texas. For a growth investor, that creates a clean narrative bridge: named geographies, pilot launch framing, and a shorter emotional distance between today’s headlines and tomorrow’s revenue expectations.
Joby’s story is better if you are underwriting durability. Archer’s story is better if you are underwriting excitement. That distinction matters.
There is also a valuation and market-structure angle. Joby’s larger capital base can be a strength, but it can also make investors think in slower-cycle terms. If you already have roughly $2.6 billion of liquidity, the market starts asking how efficiently that capital converts into certified aircraft, launch routes, and paid flights. Bigger balance sheets invite bigger expectations. Archer, by contrast, can still trade more like a high-beta commercialization narrative where investors focus on milestone sequencing rather than balance-sheet efficiency.
Another issue is that certification progress, while critical, is not always the best short-term stock catalyst. Markets often discount certification in pieces because the process is incremental and technical. A headline like “first FAA-conforming aircraft takes flight” is meaningful, but it does not create the same immediate emotional reaction as “pilot operations on track for 2026” in the U.S. and UAE. One reads like engineering progress. The other reads like market entry.
So yes, I think smart money is currently leaning harder into commercialization storytelling than into certification visibility. Not because certification is less important in the long run, but because the market tends to pay a higher multiple to the company that feels one headline closer to revenue. Joby may still be the fundamentally stronger setup on cash and regulatory depth. But ARKX’s weighting says that, for now, the faster trade is the one attached to visible launch theater. That looks bullish for Archer near term, but it also means Archer is carrying more expectation risk if those pilot timelines slip.
Q2: Archer는 2024년 초 6대, 2024년 말에는 2025년 최대 10대 생산 목표를 제시했지만, 2025년 말에는 완성 대수를 밝히지 않았고 최소 1대만 Abu Dhabi 테스트용으로 인도한 정황만 보인다. 그런데 같은 회사는 2025년 말 유동성 $2B와 2026년 미국·UAE 파일럿 프로그램 온트랙을 말한다. ‘생산 숫자를 숨긴 채 상업화 일정은 유지’하는 이 괴리는 2026년 타임라인 이탈의 시작 신호인가?
This looks like a yellow flag, not a red flag yet. But it is definitely a flag.
The production timeline matters because Archer’s own public framing changed as execution got closer. Early on, the company talked about six aircraft. By late 2024, that was framed as a goal of up to 10 aircraft in 2025. During 2025, reporting indicated six aircraft were being worked on simultaneously. Then by year-end, the company stopped giving a clean completed-aircraft number. Instead, the public picture appears to show at least one aircraft delivered for Abu Dhabi testing, without a clear final tally for total completed units.
That kind of disclosure drift usually tells you something. When a company is comfortably hitting production goals, it tends to repeat the number. When it stops repeating the number, investors should assume the number stopped helping.
At the same time, Archer said year-end 2025 liquidity was $2 billion and continued to describe the 2026 U.S. and UAE pilot programs as on track. So now the market has to reconcile two claims: strong funding and preserved launch timing on one side, but fuzzier production output on the other.
I would not call this proof that the 2026 timeline is broken. I would call it evidence that the margin for execution error is shrinking.
The reason is straightforward. Pilot programs do not require full-scale commercial fleets, so it is possible to keep a 2026 launch narrative alive with a smaller number of aircraft than investors once expected. In other words, Archer may not need anything close to 10 completed aircraft to stage pilot activity in the U.S. and UAE. A few test-ready or pilot-ready units can be enough to preserve the headline.
But that is also exactly why the production ambiguity matters. If you can maintain the commercialization narrative with a minimal fleet, the market has to ask whether the company is preserving the date while quietly lowering the operational depth behind that date. A pilot launch with very limited fleet availability is still a milestone. It is just not the same milestone investors may have imagined when production targets were expanding.
The balance sheet gives Archer room to absorb that tension. With $2 billion in liquidity, the company has the cash to keep funding certification, manufacturing, and pilot deployment work. That reduces immediate financing panic. Still, cash does not solve throughput. If actual completed aircraft are coming in below what the earlier target language implied, then the risk is not “Archer runs out of money tomorrow.” The risk is “Archer meets the letter of the 2026 milestone but misses the spirit of scalable commercial readiness.”
That would matter a lot for the stock. Archer is being supported partly because investors believe it has a clean path from pilot programs to broader deployment. If 2026 ends up being mostly symbolic rather than operationally meaningful, the market could reprice that story quickly.
So my answer is this: the gap between reduced production transparency and unchanged commercialization timing is the earliest sign of potential timeline slippage, but not definitive proof of it. I would watch whether Archer starts giving more concrete aircraft-delivery language again. If it does, concern fades. If it keeps emphasizing pilot dates while staying vague on actual completed units, then the market should assume execution is thinner than the headline suggests.
Q3: EHang은 2025년 4분기 매출 CN¥243.78M, 순이익 CN¥10.49M으로 흑자 전환했지만, 주가는 1일 -8.46%, 30일 -19.04%, 1년 -56.83%다. 게다가 매출의 약 90%가 중국에 집중돼 있다. 숫자만 보면 ‘첫 흑자’인데 시장은 왜 오히려 중국 단일시장 의존 리스크를 더 크게 가격에 반영하는가? 이 흑자는 반복 가능한 수익성 신호인가, 아니면 지리적 집중이 너무 커서 멀티플 할인을 피할 수 없는가?
The profit number is real, but the market is treating it as unproven quality earnings.
EHang reported Q4 2025 revenue of CN¥243.78 million and net income of CN¥10.49 million. In isolation, that is exactly the kind of milestone investors say they want from a frontier mobility company. It shows the business can, at least for one quarter, convert sales into profit. Normally that should help sentiment.
Instead, the stock reaction tells a different story. The shares were down 8.46% in one day, down 19.04% over 30 days, and down 56.83% over one year. Those are not the numbers of a market that suddenly believes the model has been de-risked.
The biggest reason is concentration. About 90% of EHang’s revenue is tied to China. That means investors are not just evaluating whether the company can generate profits. They are evaluating whether those profits deserve a premium multiple if they remain heavily exposed to one geography, one regulatory environment, and one commercialization ecosystem.
That is a very different question.
A single profitable quarter can always be explained two ways. The bullish read is that EHang is early but operationally ahead, and this quarter is the first sign that scale economics are beginning to appear. The bearish read is that profitability is too dependent on delivery timing, regional demand concentration, or quarter-specific mix to support a durable valuation re-rating. Right now, the market is clearly leaning toward the second interpretation.
I think that caution is understandable. If 90% of revenue comes from China, then even strong domestic execution does not fully solve the discount problem for global investors. They will still apply a haircut for concentration risk, policy sensitivity, and uncertainty around how easily the business model travels outside its home market. In that setup, profitability helps, but it does not fully change the multiple.
There is also a credibility issue around repeatability. Net income of CN¥10.49 million against CN¥243.78 million of revenue is positive, but not yet so large that investors can dismiss volatility. A relatively small swing in costs, mix, or delivery cadence could push earnings back below zero. So the market is asking a fair question: is this the beginning of a pattern, or just one good quarter inside a still-volatile scale-up phase?
My read is that EHang’s first profit is important, but not enough on its own to eliminate the valuation discount. Until investors see either repeated profitability or a meaningful reduction in geographic concentration, the stock will probably keep trading as a discounted story. That does not mean the quarter was meaningless. It means the hurdle for re-rating is higher than “one quarter in the black.”
If EHang can string together multiple profitable periods, the narrative changes. If it can also reduce the China share of revenue from roughly 90% toward something more balanced, the multiple conversation changes even faster. Until then, the market is likely to treat profitability as encouraging but not yet portable.
What to Watch Tomorrow
First, watch whether Joby’s next headlines keep pushing certification depth or begin adding more direct commercial deployment evidence. The company already has the stronger cash and regulatory profile. The missing ingredient for the stock is a sharper near-term commercialization trigger.
Second, watch whether Archer restores confidence by becoming more specific on actual aircraft output. The 2026 pilot narrative can hold for now, but vague production disclosure is the easiest way to turn bullish anticipation into timeline skepticism.
Third, watch whether EHang can prove that Q4 profitability was not a one-off. Another quarter of positive earnings would matter. Evidence that revenue is becoming less China-concentrated would matter even more.